You have 9 free searches left this month | for more free features.

oxaliplatin

Showing 26 - 50 of 922

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Metastases, Colorectal Cancer Metastatic, Colorectal Cancer Trial (Oxaliplatin)

Not yet recruiting
  • Lung Metastases
  • +2 more
  • Oxaliplatin
  • (no location specified)
Nov 3, 2022

Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)

Recruiting
  • Gastric Cancer
  • Jinan, Shandong, China
    Qilu hospital of Shandong univertisy
Mar 30, 2022

Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)

Recruiting
  • Biliary Tract Tumor
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Mar 14, 2022

Non-hodgkin Lymphoma,B Cell, Refractory DLBCL, Relapsed DLBCL Trial in United States (MT-3724, Gemcitabine, Oxaliplatin)

Terminated
  • Non-hodgkin Lymphoma,B Cell
  • +2 more
  • Orange, California
  • +8 more
Jul 18, 2022

Gastric Cancer Trial (Envolimab, Fuquinitinib, Oxaliplatin)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Jun 13, 2023

Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)

Terminated
  • Colorectal Neoplasms
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 30, 2021

Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • Oxaliplatin
  • +2 more
  • Tianjin, Tianjin, China
    Xuewei Ding
Aug 2, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)

Completed
  • Gastric Cancer
  • GastroEsophageal Cancer
  • SHR-1210
  • +3 more
  • Hefei, Anhui, China
  • +9 more
Jun 30, 2022

Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Recruiting
  • Early Low Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 9, 2023

Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced Colon Cancer
  • (no location specified)
Feb 16, 2023

Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

Not yet recruiting
  • Advanced Solid Tumor
  • JS015
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 17, 2023

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Rectal Neoplasms
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 27, 2023

Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,

Recruiting
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    The Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022

Colorectal Tumors, Stomach Tumor, Esophageal Tumors Trial in Cork, Dublin 8 (Lithium, Oxaliplatin, Capecitabine)

Recruiting
  • Colorectal Neoplasms
  • +2 more
  • Cork, Ireland
  • +1 more
Feb 9, 2022

Liver Cancer Trial in France (Oxaliplatin, Irofulven)

Completed
  • Liver Cancer
  • Bordeaux, France
  • +6 more
Nov 24, 2021

Colorectal Carcinoma Trial in Guangzhou (Sintilimab, Oxaliplatin, capecitabine)

Recruiting
  • Colorectal Carcinoma
  • Guangzhou, China
    Sun Yat-sen University
Dec 29, 2022

Immunotherapy Trial (Tislelizumab, Capecitabine, oxaliplatin)

Not yet recruiting
  • Immunotherapy
  • (no location specified)
Jul 28, 2022

Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)

Not yet recruiting
  • Extranodal NK/T-cell Lymphoma
  • Sugemalimab
  • +4 more
  • (no location specified)
Jan 17, 2023

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

Active, not recruiting
  • Mucinous Adenocarcinoma of the Rectum
  • +7 more
  • bevacizumab
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 5, 2022

Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)

Not yet recruiting
  • Colon Neoplasm
  • Oxaliplatin
  • +4 more
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Jun 25, 2023

Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With

Enrolling by invitation
  • Gastric Cancer
  • Gastrectomy
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan hospital
May 1, 2022

Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Amiens, France
  • +20 more
Jul 26, 2022

Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)

Recruiting
  • Pancreas Cancer
  • Adenocarcinoma of the Pancreas
  • Omaha, Nebraska
    University of Nebraska Medical Center
Mar 31, 2022